Likely Diagnosis: Herpes Zoster (Shingles)
The clinical images are highly consistent with early herpes zoster (shingles). Here is a full breakdown:
What the Images Show
The rash on the back demonstrates:
- Clustered erythematous papules and small vesicles on an erythematous base
- Grouped arrangement (not scattered/diffuse)
- Unilateral distribution, appearing to follow a dermatomal pattern on the back/flank
- Multiple satellite smaller clusters nearby - the classic "shotgun" grouping of zoster
Compare with the textbook image of confirmed herpes zoster:
The morphology closely matches Fig. 19.16 from Andrews' Diseases of the Skin.
Pathophysiology
Herpes zoster results from reactivation of varicella-zoster virus (VZV), which lies dormant in dorsal root ganglion cells after primary chickenpox infection. Triggers include age-related immune decline, immunosuppression (HIV, TNF inhibitors, JAK inhibitors, malignancy, steroids), diabetes, and autoimmune disease. The virus travels down the sensory nerve to the skin.
Key Diagnostic Features
| Feature | This Patient |
|---|
| Grouped vesicles/papules | Present |
| Erythematous base | Present |
| Unilateral, dermatomal | Appears unilateral on back |
| Back/thoracic dermatome | Yes (thoracic is most common - 55%) |
Ask the patient about:
- Prodromal burning, stinging, or shooting pain/itching in that area (1-5 days before rash)
- Prior chickenpox history
- Fever, malaise, headache
- Whether rash crosses the midline (it should not in typical zoster)
- Age and immune status (HIV, malignancy, immunosuppressive medications)
Differential Diagnosis
| Diagnosis | Against it here |
|---|
| Herpes simplex (HSV) | Less common on trunk/back, no prodromal dermatomal pain pattern |
| Contact dermatitis | Would not have grouped vesicles, not dermatomal |
| Insect bites | Usually more scattered, urticarial |
| Impetigo | Honey-crusted, not grouped vesicles on erythematous base |
Management
Antiviral therapy - start within 72 hours of rash onset (benefits still possible up to 7 days):
| Drug | Dose (Adults) | Duration |
|---|
| Valacyclovir (preferred) | 1000 mg TID | 7 days |
| Famciclovir | 500 mg TID | 7 days |
| Acyclovir | 800 mg 5x/day | 7-10 days |
Pain control: Acetaminophen, NSAIDs, or opioids if severe. Cool compresses for local relief.
Watch for red flags requiring urgent referral:
- Rash near the eye (ophthalmic branch V1) or tip of nose (Hutchinson sign) - ophthalmology emergency
- More than 20 lesions outside the dermatome (disseminated zoster - needs IV acyclovir)
- Immunocompromised patient - consider IV acyclovir
- Motor weakness
Postherpetic Neuralgia (PHN) Prevention
PHN (pain persisting >1 month after healing) occurs in up to 40% of patients over 60 years old, but <10% under 60. Early antiviral treatment reduces both severity and PHN incidence.
Vaccination
Recombinant zoster vaccine (Shingrix) is recommended for adults 50+ years old - it reduces zoster incidence by ~90%. If this patient hasn't been vaccinated, counsel on vaccination after the acute episode resolves.
Disclaimer: This analysis is for clinical decision support. Confirm with full history, physical exam, and clinical judgment. In atypical cases, consider viral PCR or Tzanck smear for confirmation.
Sources: Andrews' Diseases of the Skin, 13e; Textbook of Family Medicine, 9e